No description available.

The transdermal delivery of drugs has a lot of advantages above other routes of delivery, such as the avoidance of first-pass hepatic and intestinal metabolism, the non-invasive infusion of drugs, etc. However, the transdermal delivery of drugs, especially hydrophilic drugs, is limited due to the lipophilic nature of the stratum corneum. Methotrexate is a folic acid antagonist with antineoplastic activity and is used for the treatment of psoriasis and Kaposi's sarcoma. The permeation of methotrexate through the skin for systemic use is however limited due to its high molecular weight, the fact that it is mainty dissociated at physiological pH and its hydrophilic nature (Alvarez-Figueroa et al.. 2001). Thus the aim of my study was to enhance the permeation of methotrexate with the use of terpene. Terpenes are lipophilic in nature and have Log P values of around 2-4 (Godwin & Michniak, 1999). These characteristics make them excellent candidates as penetration enhancers. Terpenes are not only used for penetration enhancers, but in a huge number of other products, such as aromatherapeutic oils. For this reason the permeation of the terpenes through human skin and the effect of methotrexate on this permeation were also determined. The following enhancers were used in this study: menthol, menthone. isomenthol, limonene, B-myrcene, a-pinene and 1,8-cineole Five different sets of experiments were done in this study: a) a control experiment with methotrexate in the absence of the terpenes without ethanol; b) a control experiment with methotrexate in the absence of the terpenes with ethanol: c) experiments with methotrexate in the presence of the terpenes; d) control experiments with the terpenes in the absence of methotrexate and e) experiments with tile terpenes in the presence of methotrexate. For this study only human female abdominal skin was used. A saturated solution of methotrexate in water:propylene glycol (50:50) with a pH between 4 and 5 (Vaidyanathan et al., 1985) was used as the model drug and the receptor phase was PBS-buffer (pH=74) and water:ethanol (50:50) for HPLC and GC analysis respectively. The dilfusion apparatus used consisted of Vertical Franz diffusion cells with a capacity of 2 ml and a diffusion area of 1.075 cm2. The cells were placed in a water bath (+- 37 "C) on magnetic stirrers for the duration of the experiment. After the receptor phase was placed in the receptor compartment the cells were equilibrated for an hour before putting 25 ul of a 5% terpene solution in absolute ethanol on the skin in the donor compartment. This was left for half and hour to allow evaporation of the ethanol. The saturated solution of the methotrexate was now placed on the skin in the donor compartment. The experiments for methotrexate stretched over a period of 12 hours and samples were collected every 2 hours. The terpene experiments were performed over a 24-hour period and samples were taken at 2,4,6,12 and 24 hours. The concentration methotrexate permeated was determined by using HPLC-analysis and terpenes by using GC-analysis. The flux (ug/cm2/h), kp(cm/h), lag time (h) and enhancement ratio were calculated to compare the methotrexate permeation in the control and actual experiments. The results showed that a-pinene, B-myrcene and isomenthol enhanced the permeation of methotrexate most, although all the terpenes had an enhancing effect. They produced a 4- fold increase in the flux values of methotrexate. Due to the fact that the terpene experiments were only a semi-quantitative evaluation only the percentage terpenes that permeated was calculated. The experiments were done on all the terpenes except apinene. All the terpenes permeated the skin with menthol having the highest permeation. The results also showed that methotrexate did have an effect on the terpene permeation. Menthone and menthol's permeation was higher in the presence of methotrexate, while the other terpenes had a higher permeation in the absence of methotrexate. The reason for this is not clear. In conclusion, the study revealed that the enhancers used did have an enhancing effect on methotrexate permeation. This could be due to the extraction or disruption of lipids by the terpenes (Zhoa & Singh, 2000) or an increase in diffusivity and partitioning. The terpene experiments also showed that the terpenes do permeate the skin and that methotrexate does have an effect on this permeation. / Thesis (M.Sc.)--North-West University, Potchefstroom Campus, 2004.

The transdermal delivery of drugs has a lot of advantages above other routes of delivery, such as the avoidance of first-pass hepatic and intestinal metabolism, the non-invasive infusion of drugs, etc. However, the transdermal delivery of drugs, especially hydrophilic drugs, is limited due to the lipophilic nature of the stratum corneum. Methotrexate is a folic acid antagonist with antineoplastic activity and is used for the treatment of psoriasis and Kaposi's sarcoma. The permeation of methotrexate through the skin for systemic use is however limited due to its high molecular weight, the fact that it is mainty dissociated at physiological pH and its hydrophilic nature (Alvarez-Figueroa et al.. 2001). Thus the aim of my study was to enhance the permeation of methotrexate with the use of terpene. Terpenes are lipophilic in nature and have Log P values of around 2-4 (Godwin & Michniak, 1999). These characteristics make them excellent candidates as penetration enhancers. Terpenes are not only used for penetration enhancers, but in a huge number of other products, such as aromatherapeutic oils. For this reason the permeation of the terpenes through human skin and the effect of methotrexate on this permeation were also determined. The following enhancers were used in this study: menthol, menthone. isomenthol, limonene, B-myrcene, a-pinene and 1,8-cineole Five different sets of experiments were done in this study: a) a control experiment with methotrexate in the absence of the terpenes without ethanol; b) a control experiment with methotrexate in the absence of the terpenes with ethanol: c) experiments with methotrexate in the presence of the terpenes; d) control experiments with the terpenes in the absence of methotrexate and e) experiments with tile terpenes in the presence of methotrexate. For this study only human female abdominal skin was used. A saturated solution of methotrexate in water:propylene glycol (50:50) with a pH between 4 and 5 (Vaidyanathan et al., 1985) was used as the model drug and the receptor phase was PBS-buffer (pH=74) and water:ethanol (50:50) for HPLC and GC analysis respectively. The dilfusion apparatus used consisted of Vertical Franz diffusion cells with a capacity of 2 ml and a diffusion area of 1.075 cm2. The cells were placed in a water bath (+- 37 "C) on magnetic stirrers for the duration of the experiment. After the receptor phase was placed in the receptor compartment the cells were equilibrated for an hour before putting 25 ul of a 5% terpene solution in absolute ethanol on the skin in the donor compartment. This was left for half and hour to allow evaporation of the ethanol. The saturated solution of the methotrexate was now placed on the skin in the donor compartment. The experiments for methotrexate stretched over a period of 12 hours and samples were collected every 2 hours. The terpene experiments were performed over a 24-hour period and samples were taken at 2,4,6,12 and 24 hours. The concentration methotrexate permeated was determined by using HPLC-analysis and terpenes by using GC-analysis. The flux (ug/cm2/h), kp(cm/h), lag time (h) and enhancement ratio were calculated to compare the methotrexate permeation in the control and actual experiments. The results showed that a-pinene, B-myrcene and isomenthol enhanced the permeation of methotrexate most, although all the terpenes had an enhancing effect. They produced a 4- fold increase in the flux values of methotrexate. Due to the fact that the terpene experiments were only a semi-quantitative evaluation only the percentage terpenes that permeated was calculated. The experiments were done on all the terpenes except apinene. All the terpenes permeated the skin with menthol having the highest permeation. The results also showed that methotrexate did have an effect on the terpene permeation. Menthone and menthol's permeation was higher in the presence of methotrexate, while the other terpenes had a higher permeation in the absence of methotrexate. The reason for this is not clear. In conclusion, the study revealed that the enhancers used did have an enhancing effect on methotrexate permeation. This could be due to the extraction or disruption of lipids by the terpenes (Zhoa & Singh, 2000) or an increase in diffusivity and partitioning. The terpene experiments also showed that the terpenes do permeate the skin and that methotrexate does have an effect on this permeation. / Thesis (M.Sc.)--North-West University, Potchefstroom Campus, 2004.

No description available.

No description available.

No description available.

A exposição à radiação ultravioleta (RUV) pode levar a um desequilíbrio no balanço oxidante/antioxidante da pele causando prejuízos à sua integridade e levando a diversas alterações, entre as quais o envelhecimento precoce e o câncer de pele. Na tentativa de diminuir os efeitos biológicos mediados pelos radicais livres gerados pela RUV na pele, tem sido proposto a fotoquimioproteção com a utilização de antioxidantes tópicos. Dentre a gama de compostos disponíveis para serem empregados na fotoquimioproteção, a própolis, por sua pronunciada atividade antioxidante, entre suas inúmeras atividades biológicas, é uma matéria-prima com promissora ação tópica. Desta forma, extratos de própolis alcoólico e glicólico (EPA e EPG) foram caracterizados quanto à sua composição polifenólica e quanto à sua capacidade antioxidante frente a diversos radicais livres. Formulações adicionadas destes extratos foram desenvolvidas e submetidas a estudos de estabilidade física e funcional, estudos de liberação, permeação e retenção cutânea in vitro, bem como estudos preliminares de eficácia in vivo. Os resultados demonstraram que os extratos de própolis são capazes de seqüestrar eficientemente diversos radicais livres, principalmente radicais superóxido. Quando estes extratos foram adicionados em formulações de produtos para uso tópico, a atividade antioxidante foi mantida. Nos estudos prévios de estabilidade física foi observado que as formulações mais estáveis foram desenvolvidas com Hostacerin® SAF (menor conteúdo graxo) e Polawax® (maior conteúdo graxo). No entanto, somente a formulação desenvolvida com Polawax® apresentou estabilidade satisfatória por 1 ano quando armazenada à temperatura ambiente e a 40º.C 2º.C/70%UR 5%. Nos estudos de liberação, permeação e retenção cutânea foi observado a influência do conteúdo graxo na performance das formulações. A cinética de liberação das formulações tanto do ácido p-cumárico (utilizado como marcador), como dos compostos equivalentes ao extrato de própolis (EEP) demonstraram seguir o modelo de Higuchi. A formulação desenvolvida com Polawax® apresentou a melhor retenção cutânea, com retenção de 0,013 e 0,030 µL de EEP.cm-2 para as peles de camundongo e de porco, respectivamente. Em adição, esta formulação apresentou baixos níveis de permeação cutânea, sendo adequada para aplicação tópica fotoquimioprotetora. Nos estudos in vivo, esta formulação adicionada de EPA, foi capaz de diminuir o eritema, inibir o edema e aumentar a cicatrização de camundongos sem pêlo expostos à radiação UVB. Além disso, também foi observado a proteção da depleção da glutationa endógena (GSH). Os resultados preliminares de eficácia in vivo sugerem que formulações contendo o extrato de própolis apresentam boas perspectivas para serem utilizadas para prevenir e tratar os danos causados na pele pela radiação UV. / The ultraviolet radiation (UVR) exposition may lead to the skin oxidant/antioxidant imbalance injuring its integrity and leading to several disorders, such as ageing and skin cancer. In order to improve the biological effects caused by free radicals generated by UVR in skin, it has been suggested the photochemoprotection by using topical antioxidants. Among the available compounds to be employed in hotochemoprotection, propolis, due to its important antioxidant activity, among its innumerous biological activities, is a promising topical raw-material. Next, ethanolic and glycolic propolis extracts (EPE, GPE) were characterized in relation to their polyphenolic composition, and in relation to their antioxidant activity against several free-radicals. Formulations added with these extracts were developed and undergone to physical and functional stability studies, in vitro release and skin permeation and retention studies, as well as in vivo preliminary efficacy studies. The results showed that the propolis extracts are able to scavenge several free radicals efficiently, mainly superoxide radicals. When these extracts were added to formulations of topical products, their antioxidant activity were maintained. In the physical stability studies, it was observed that the most stable formulations were developed with Hostacerin® SAF (lower fat content) and Polawax® (higher fat content). However, only the formulation developed with Polawax® showed satisfactory stability for 1 year stored at room temperature and at 40º.C 2º.C/70%UR 5%UR. In the release, permeation and retention studies, it was observed the fat content influence in the formulation performance. The release profile of p-coumaric acid (used as marker compound) and the compounds equivalent to propolis extract (EPE) followed the Higuchi model. The formulation developed with Polawax® showed the best skin retention, retaining 0,013 and 0,030 L EPE.cm-2 in hairless mouse skin and in pig skin, respectively. In addition, this formulation presented low permeation, which is desired for photochemoprotective topical employment. In the in vivo studies, this formulation added with EPE was able to diminish erithema, inhibit oedema and increase cicatrisation in hairless mice exposed to UVB radiation. In addition, it was also observed the protection of the endogenous glutathione (GSH) depletion. The in vivo preliminary efficacy results suggest that formulations added with propolis extract present good perspectives to be employed to prevent and treat the injuries caused in skin by UV radiation.

A reposição estrogênica na pós-menopausa revela-se através de benefícios na melhora da qualidade de vida, prevenção e cura da osteoporose, bem como na diminuição da incidência de doenças cardiovasculares. A via percutânea apresenta grande interesse devido a fatores como, manutenção de níveis plasmáticos e eliminação da primeira passagem hepática, responsável pelo surgimento de efeitos colaterais adversos, aliados a relativa simplicidade de desenvolvimento e produção, facilidade na aplicação e versatilidade. Neste trabalho foram viabilizadas formulações de géis hidroalcoólicos contendo estradiol com diferentes bases, adaptando e desenvolvendo metodologias para determinação de características físicas, químicas e tecnológicas, como espalhabilidade, consistência, liodisponibilidade, teor da substância ativa e conservantes, bem como ensaios preliminares de penetração na pele, e em membranas artificiais e de estabilidade física e química de estradiol e dos conservantes. Verificou-se que dois dos gíss desenvolvidos, com bases de carbômero (Carbopol 940®) e hidroxietilcelulose (Cellosize QP 100®), apresentaram características apropriadas no que diz respeito a consistência, espalhabilidade e promoção da penetração de estradiol através da pele. Esta foi avaliada através do desenvolvimento ponderal uterino de ratas castradas e determinação dos níveis séricos de estradiol por fluorimunoensaio, não havendo diferença significativa entre os produtos neste ensaio. Ambas as formulações mostraram-se estáveis fisicamente, porém, o produto desenvolvido com base de hidroxietilcelulose apresentou degradação significativa de estradiol. Os ensaios de absorção de estradiol em membranas artificiais não diferenciou significativamente as formulações quanto ao tipo de base e tempo de exposição, observou-se entretanto, que existe uma relação entre a quantidade aplicada de gel e de estradiol absorvido. / The hormonal replacement therapy for menopausal symptoms intents the healing and prevention of osteoporosis, the decrease of the incidence of cardiovascular diseases as well the improvement of life quality, affording relief from any of a long list of subjective complaints. The election of a transdermal estradiol formulation is due to its abilities to bypass the liver resulting adequate hormonal plasmatic levels. In addition, it is considerably simple to manufacture and to adapt to individual dosages. This research aims the formulation of estradiol as an hydroalcoholic gel using different gelformers. The development and adaptation of methodologies to perform the physical, chemical and biological characterization of the formulated products were also realized. Two of the formulated gels showed appropriate characteristics of consistence, spreading and skin permeation. They were prepared with carbomer (Carbopol 940) and hydroxiethylcellulose (Cellosize QP 100). Biological evaluation was performed by the essay of the uterusweight of castrated rats and by immunofluorescence assay. The statistical analysis showed no differences between the methods and gels. The stability test for the two formulations yielded good physical stability results but the hydroxyethylcellulose gel showed significant estradiol degradation. Although the gels artificial membrane absorptions didn't differ when submeted to difference contact times, it was detected a kind of relationship between the applied gel amount and the absorbed estradiol.

A exposição à radiação ultravioleta (RUV) pode levar a um desequilíbrio no balanço oxidante/antioxidante da pele causando prejuízos à sua integridade e levando a diversas alterações, entre as quais o envelhecimento precoce e o câncer de pele. Na tentativa de diminuir os efeitos biológicos mediados pelos radicais livres gerados pela RUV na pele, tem sido proposto a fotoquimioproteção com a utilização de antioxidantes tópicos. Dentre a gama de compostos disponíveis para serem empregados na fotoquimioproteção, a própolis, por sua pronunciada atividade antioxidante, entre suas inúmeras atividades biológicas, é uma matéria-prima com promissora ação tópica. Desta forma, extratos de própolis alcoólico e glicólico (EPA e EPG) foram caracterizados quanto à sua composição polifenólica e quanto à sua capacidade antioxidante frente a diversos radicais livres. Formulações adicionadas destes extratos foram desenvolvidas e submetidas a estudos de estabilidade física e funcional, estudos de liberação, permeação e retenção cutânea in vitro, bem como estudos preliminares de eficácia in vivo. Os resultados demonstraram que os extratos de própolis são capazes de seqüestrar eficientemente diversos radicais livres, principalmente radicais superóxido. Quando estes extratos foram adicionados em formulações de produtos para uso tópico, a atividade antioxidante foi mantida. Nos estudos prévios de estabilidade física foi observado que as formulações mais estáveis foram desenvolvidas com Hostacerin® SAF (menor conteúdo graxo) e Polawax® (maior conteúdo graxo). No entanto, somente a formulação desenvolvida com Polawax® apresentou estabilidade satisfatória por 1 ano quando armazenada à temperatura ambiente e a 40º.C 2º.C/70%UR 5%. Nos estudos de liberação, permeação e retenção cutânea foi observado a influência do conteúdo graxo na performance das formulações. A cinética de liberação das formulações tanto do ácido p-cumárico (utilizado como marcador), como dos compostos equivalentes ao extrato de própolis (EEP) demonstraram seguir o modelo de Higuchi. A formulação desenvolvida com Polawax® apresentou a melhor retenção cutânea, com retenção de 0,013 e 0,030 µL de EEP.cm-2 para as peles de camundongo e de porco, respectivamente. Em adição, esta formulação apresentou baixos níveis de permeação cutânea, sendo adequada para aplicação tópica fotoquimioprotetora. Nos estudos in vivo, esta formulação adicionada de EPA, foi capaz de diminuir o eritema, inibir o edema e aumentar a cicatrização de camundongos sem pêlo expostos à radiação UVB. Além disso, também foi observado a proteção da depleção da glutationa endógena (GSH). Os resultados preliminares de eficácia in vivo sugerem que formulações contendo o extrato de própolis apresentam boas perspectivas para serem utilizadas para prevenir e tratar os danos causados na pele pela radiação UV. / The ultraviolet radiation (UVR) exposition may lead to the skin oxidant/antioxidant imbalance injuring its integrity and leading to several disorders, such as ageing and skin cancer. In order to improve the biological effects caused by free radicals generated by UVR in skin, it has been suggested the photochemoprotection by using topical antioxidants. Among the available compounds to be employed in hotochemoprotection, propolis, due to its important antioxidant activity, among its innumerous biological activities, is a promising topical raw-material. Next, ethanolic and glycolic propolis extracts (EPE, GPE) were characterized in relation to their polyphenolic composition, and in relation to their antioxidant activity against several free-radicals. Formulations added with these extracts were developed and undergone to physical and functional stability studies, in vitro release and skin permeation and retention studies, as well as in vivo preliminary efficacy studies. The results showed that the propolis extracts are able to scavenge several free radicals efficiently, mainly superoxide radicals. When these extracts were added to formulations of topical products, their antioxidant activity were maintained. In the physical stability studies, it was observed that the most stable formulations were developed with Hostacerin® SAF (lower fat content) and Polawax® (higher fat content). However, only the formulation developed with Polawax® showed satisfactory stability for 1 year stored at room temperature and at 40º.C 2º.C/70%UR 5%UR. In the release, permeation and retention studies, it was observed the fat content influence in the formulation performance. The release profile of p-coumaric acid (used as marker compound) and the compounds equivalent to propolis extract (EPE) followed the Higuchi model. The formulation developed with Polawax® showed the best skin retention, retaining 0,013 and 0,030 L EPE.cm-2 in hairless mouse skin and in pig skin, respectively. In addition, this formulation presented low permeation, which is desired for photochemoprotective topical employment. In the in vivo studies, this formulation added with EPE was able to diminish erithema, inhibit oedema and increase cicatrisation in hairless mice exposed to UVB radiation. In addition, it was also observed the protection of the endogenous glutathione (GSH) depletion. The in vivo preliminary efficacy results suggest that formulations added with propolis extract present good perspectives to be employed to prevent and treat the injuries caused in skin by UV radiation.

Percutaneous delivery of drugs promises many advantages over oral or intravenous administration, such as a better control of blood levels, a reduced incidence of systemic toxicity, an absence of hepatic first-pass metabolism, better patient compliance, etc. However, the dermal drug transport is limited by the unsuitable physicochemical properties of most drugs and the efficient barrier function of the skin. Thus, numerous attempts have been reported to improve topical absorption of drugs, concentrating mainly on the barrier function of the stratum corneum by use of penetration enhancers and/or skin warming. An alternative and interesting possibility for improved dermal permeability is the synthesis of derivatives or analogues with the aim of changing the physicochemical properties in favour of skin permeation, efficacy and therapeutic value. Cyclizine (I) is an anti-emetic drug primarily indicated for the prophylaxis and treatment of nausea and vomiting associated with motion sickness, post operation and Meniere's disease. It acts both on the emetic trigger zone and by damping the labyrinthine sensitivity. Pharmacologically it has anti-histaminic, antiserotonergic, local anaesthetic and vagolytic actions. It is widely used and also suitable for children from six year of age. Percutaneous absorption of (I) can, among others, avoid the "first-pass" effect and the discomfort of injection. The main objective of this study was to explore the feasibility of percutaneous absorption of (I) and its alkyl analogues via physicochemical characterization and assessment of their permeation parameters. The intent was also to establish a correlation between the physicochemical properties of these compounds and their percutaneous rate of absorption. To achieve these objectives, the study was undertaken by synthesizing the alkyl analogues and determining the physicochemical parameters relevant to skin transport. Identification and level of purity for the prepared analogues were confirmed by mass spectrometry (MS), nuclear magnetic resonance (NMR) spectrometry and infrared (IR) spectrometry. Experimental aqueous solubility (25 °c & 32 °C) and partition coefficient for each compound were determined. In vitro permeation studies were performed at pH 7.4, using Franz diffusion cells with human epidermal membranes. Diffusion experiments were conducted over a period of 24 hours maintaining a constant temperature (37 DC) by means of water bath. All samples were analysed by high pressure liquid chromatography (HPLC). Cyclizine (I) has a methyl group at N-4. Increasing the alkyl chain length on N-4 of the piperazine ring resulted' in compounds with lower melting points and higher water solubility than (I). (II) exhibited 3-fold increase in water solubility, followed by (IV) with about 2.5 fold increase. The water solubility of (III) was almost the same as that of (I). Log partition coefficients increased linearly with increasing alkyl chain length. The analogues therefore, possessed more favourable physicochemical properties to be delivered percutaneously. Indeed, the in vitro skin permeation data proved that these analogues could be delivered more easily than (I) itself. The flux of (I) was 0.132 ug/cm2/h in a saturated aqueous solution. Compound (II) resulted in a 53-fold (6.952 ug/cm2/h) increase in permeation compared to (I). (III) and (IV) resulted in a 2- and 5fold enhancement of permeation respectively. Based on the results of the study, it seems that increased aqueous solubility and low level of crystallinity play a vital role in optimizing percutaneous absorption of (I) and its alkyl analogues. But the importance of the effect of increased lipophilicity cannot be ignored. The low percutaneous• absorption of (I) might be attributed to its low aqueous solubility and increased crystallinity, as is evident from the higher melting point than the analogues. From all the permeability data using aqueous solutions, it is clear that compound (II) is the best permeant of this series and in addition it is known that this compound antagonizes the effects of histamine. / Thesis (M.Sc. (Pharm.))--North-West University, Potchefstroom Campus, 2004.